DEFB1 and prostate cancer: HBD-1 appears to have largely antitumor effects since this peptide is toxic toward late stage prostate cancer cell lines (Bullard et al., 2008), while hBD-1 expression is suppressed in malignant prostate tissue (Donald et al., 2003).